Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wunderlich

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Leukemia|September 1, 2021
The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemiaMadeline Niederkorn, Chiharu Ishikawa, Kathleen M Hueneman, et al.
The Journal of Clinical Investigation|May 10, 2014
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasmGuangyao Kong, Mark Wunderlich, David Yang, et al.
Cancers|February 10, 2024
Inhibition of Enhancer of Zeste Homolog 2 Induces Blast Differentiation, Impairs Engraftment and Prolongs Survival in Murine Models of Acute Myeloid LeukemiaSydney Fobare, Ola A Elgamal, Mark Wunderlich, et al.
Blood|May 12, 2023
Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AMLJoshua Bennett, Chiharu Ishikawa, Puneet Agarwal, et al.
Cancer Cell|November 16, 2016
Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic LeukemiaShan Lin, Roger T Luo, Anetta Ptasinska, et al.
Cell Reports|January 26, 2022
Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2Huanhuan Zhao, Jun Lu, Tong Yan, et al.
Cancer Discovery|July 1, 2021
Tumor Microenvironment-Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade TherapyYuting Tang, Qian Xu, Liang Hu, et al.
Cancer Cell|July 13, 2013
Targeting IRAK1 as a therapeutic approach for myelodysplastic syndromeGarrett W Rhyasen, Lyndsey Bolanos, Jing Fang, et al.
Leukemia|July 16, 2025
Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilizationEric J Vick, Aishlin Hassan, Kwangmin Choi, et al.
Leukemia|November 28, 2019
Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALLSonia Rodriguez, Christina Abundis, Francesco Boccalatte, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Leukemia|September 1, 2021
The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemiaMadeline Niederkorn, Chiharu Ishikawa, Kathleen M Hueneman, et al.
The Journal of Clinical Investigation|May 10, 2014
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasmGuangyao Kong, Mark Wunderlich, David Yang, et al.
Cancers|February 10, 2024
Inhibition of Enhancer of Zeste Homolog 2 Induces Blast Differentiation, Impairs Engraftment and Prolongs Survival in Murine Models of Acute Myeloid LeukemiaSydney Fobare, Ola A Elgamal, Mark Wunderlich, et al.
Blood|May 12, 2023
Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AMLJoshua Bennett, Chiharu Ishikawa, Puneet Agarwal, et al.
Cancer Cell|November 16, 2016
Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic LeukemiaShan Lin, Roger T Luo, Anetta Ptasinska, et al.
Cell Reports|January 26, 2022
Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2Huanhuan Zhao, Jun Lu, Tong Yan, et al.
Cancer Discovery|July 1, 2021
Tumor Microenvironment-Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade TherapyYuting Tang, Qian Xu, Liang Hu, et al.
Cancer Cell|July 13, 2013
Targeting IRAK1 as a therapeutic approach for myelodysplastic syndromeGarrett W Rhyasen, Lyndsey Bolanos, Jing Fang, et al.
Leukemia|July 16, 2025
Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilizationEric J Vick, Aishlin Hassan, Kwangmin Choi, et al.
Leukemia|November 28, 2019
Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALLSonia Rodriguez, Christina Abundis, Francesco Boccalatte, et al.
Pageof 12